期刊
TRENDS IN BIOCHEMICAL SCIENCES
卷 34, 期 12, 页码 640-647出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibs.2009.07.008
关键词
-
资金
- La Ligue contre le Cancer
- CNRS
- Agence Nationale de la Recherche [AN-R-07-BLAN-0093]
- National Institutes of Health [RO1GM 046454]
- Houston Endowment, Inc
BTG/TOB factors are a family of antiproliferative proteins whose expression is altered in numerous cancers. They have been implicated in cell differentiation, development and apoptosis. Although proposed to affect transcriptional regulation, these factors interact with CAF1, a subunit of the main eukaryotic deadenylase, and with poly(A)-binding-proteins, strongly suggesting a role in post-transcriptional regulation of gene expression. The recent determination of the structures of BTG2, TOB1N-terminal domain (TOB1N138) and TOB1N138-CAF1 complexes support a role for BTG/TOB proteins in mRNA deadenylation, a function corroborated by recently published functional characterizations. We highlight molecular mechanisms by which BTG/TOB proteins influence deadenylation and discuss the need for a better understanding of BTG/TOB physiological functions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据